Patent · US Expired

Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain

US6696447B2 · kind B2 · utility

8Cited by
5References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 27, 2002
Grant dateFeb 24, 2004
Priority date
Expiry dateSep 27, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D333/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application describes compounds of general formula I where R1 is selected from any one of pyridinyl, thienyl, furanyl, imidazolyl, and triazolyl;and where each R1 heteroaromatic ring may optionally and independently be further substituted by 1, 2 or 3 substituents selected from straight and branched C1-C6 alkyl, NO2, CF3, C1-C6 alkoxy, chloro, fluoro, bromo, and iodo. The substitutions on the heteroaromatic ring may take place in any position on the ring system. The invention also includes enantiomers, salts and pharmaceutical compositions containing the compounds. The compounds may be used in treating patients for pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.